248 related articles for article (PubMed ID: 9369420)
21. Apoptosis of antigen-specific T lymphocytes upon the engagement of CD8 by soluble HLA class I molecules is Fas ligand/Fas mediated: evidence for the involvement of p56lck, calcium calmodulin kinase II, and Calcium-independent protein kinase C signaling pathways and for NF-kappaB and NF-AT nuclear translocation.
Contini P; Ghio M; Merlo A; Poggi A; Indiveri F; Puppo F
J Immunol; 2005 Dec; 175(11):7244-54. PubMed ID: 16301629
[TBL] [Abstract][Full Text] [Related]
22. Fas and Fas ligand expression in cystic fibrosis airway epithelium.
Durieu I; Amsellem C; Paulin C; Chambe MT; Bienvenu J; Bellon G; Pacheco Y
Thorax; 1999 Dec; 54(12):1093-8. PubMed ID: 10567629
[TBL] [Abstract][Full Text] [Related]
23. Fas and Fas-ligand expression in human pancreatic cancer.
Kornmann M; Ishiwata T; Kleeff J; Beger HG; Korc M
Ann Surg; 2000 Mar; 231(3):368-79. PubMed ID: 10714630
[TBL] [Abstract][Full Text] [Related]
24. Helicobacter pylori modulates lymphoepithelial cell interactions leading to epithelial cell damage through Fas/Fas ligand interactions.
Wang J; Fan X; Lindholm C; Bennett M; O'Connoll J; Shanahan F; Brooks EG; Reyes VE; Ernst PB
Infect Immun; 2000 Jul; 68(7):4303-11. PubMed ID: 10858249
[TBL] [Abstract][Full Text] [Related]
25. The involvement of Fas-Fas ligand pathway in fibrosing lung diseases.
Kuwano K; Miyazaki H; Hagimoto N; Kawasaki M; Fujita M; Kunitake R; Kaneko Y; Hara N
Am J Respir Cell Mol Biol; 1999 Jan; 20(1):53-60. PubMed ID: 9870917
[TBL] [Abstract][Full Text] [Related]
26. Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer.
Müllauer L; Mosberger I; Grusch M; Rudas M; Chott A
J Pathol; 2000 Jan; 190(1):20-30. PubMed ID: 10640988
[TBL] [Abstract][Full Text] [Related]
27. Expression of Fas and Fas ligand and apoptosis in tumor-associated lymphocytes and in tumor cells from malignant pleural effusions.
Sikora J; Dworacki G; Zeromski J
Nat Immun; 1998; 16(5-6):244-55. PubMed ID: 11061592
[TBL] [Abstract][Full Text] [Related]
28. Human pancreatic cancer cells express non-functional Fas receptors and counterattack lymphocytes by expressing Fas ligand; a potential mechanism for immune escape.
Elnemr A; Ohta T; Yachie A; Kayahara M; Kitagawa H; Ninomiya I; Fushida S; Fujimura T; Nishimura G; Shimizu K; Miwa K
Int J Oncol; 2001 Jan; 18(1):33-9. PubMed ID: 11115536
[TBL] [Abstract][Full Text] [Related]
29. Tumour Fas ligand:Fas ratio greater than 1 is an independent marker of relative resistance to tamoxifen therapy in hormone receptor positive breast cancer.
Reimer T; Koczan D; Müller H; Friese K; Thiesen HJ; Gerber B
Breast Cancer Res; 2002; 4(5):R9. PubMed ID: 12223126
[TBL] [Abstract][Full Text] [Related]
30. [Protein expressions of Fas and FasL in B-cell lymphoma and their significances].
Jin Y; Li YC; Su ZL; Tang LY; Feng ZY; Guo SZ
Ai Zheng; 2005 Mar; 24(3):332-6. PubMed ID: 15757536
[TBL] [Abstract][Full Text] [Related]
31. Vascular endothelial cells and smooth muscle cells differ in expression of Fas and Fas ligand and in sensitivity to Fas ligand-induced cell death: implications for vascular disease and therapy.
Sata M; Suhara T; Walsh K
Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):309-16. PubMed ID: 10669625
[TBL] [Abstract][Full Text] [Related]
32. Analysis of Fas and Fas ligand expression and function in lung cancer cell lines.
Kawasaki M; Kuwano K; Nakanishi Y; Hagimoto N; Takayama K; Pei XH; Maeyama T; Yoshimi M; Hara N
Eur J Cancer; 2000 Mar; 36(5):656-63. PubMed ID: 10738132
[TBL] [Abstract][Full Text] [Related]
33. HLA class II-mediated death is induced via Fas/Fas ligand interactions in human splenic B lymphocytes.
Truman JP; Choqueux C; Tschopp J; Vedrenne J; Le Deist F; Charron D; Mooney N
Blood; 1997 Mar; 89(6):1996-2007. PubMed ID: 9058721
[TBL] [Abstract][Full Text] [Related]
34. Expression of the apoptosis-inducing ligands FasL and TRAIL in malignant and benign human breast tumors.
Herrnring C; Reimer T; Jeschke U; Makovitzky J; Krüger K; Gerber B; Kabelitz D; Friese K
Histochem Cell Biol; 2000 Mar; 113(3):189-94. PubMed ID: 10817673
[TBL] [Abstract][Full Text] [Related]
35. Thymic atrophy via estrogen-induced apoptosis is related to Fas/FasL pathway.
Yao G; Hou Y
Int Immunopharmacol; 2004 Feb; 4(2):213-21. PubMed ID: 14996413
[TBL] [Abstract][Full Text] [Related]
36. Regulation of Fas and FasL expression on rat Schwann cells.
Wohlleben G; Ibrahim SM; Schmidt J; Toyka KV; Hartung HP; Gold R
Glia; 2000 Jun; 30(4):373-81. PubMed ID: 10797617
[TBL] [Abstract][Full Text] [Related]
37. Sensitivity to Fas-mediated apoptosis is null or weak in B-cell non-Hodgkin's lymphomas and is moderately increased by CD40 ligation.
Xerri L; Bouabdallah R; Devilard E; Hassoun J; Stoppa AM; Birg F
Br J Cancer; 1998 Jul; 78(2):225-32. PubMed ID: 9683298
[TBL] [Abstract][Full Text] [Related]
38. Activation and activation-induced death of human tonsillar B cells and Burkitt lymphoma cells: lack of CD95 (Fas/APO-1) ligand expression and function.
Daniel PT; Oettinger U; Mapara MY; Bommert K; Bargou R; Dörken B
Eur J Immunol; 1997 Apr; 27(4):1029-34. PubMed ID: 9130660
[TBL] [Abstract][Full Text] [Related]
39. Irradiation-induced up-regulation of Fas in esophageal squamous cell carcinoma is not accompanied by Fas ligand-mediated apoptosis.
Rigberg DA; Centeno J; Kim FS; Ke B; Swenson K; Maggard M; McFadden DW
J Surg Oncol; 1999 Jun; 71(2):91-6. PubMed ID: 10389864
[TBL] [Abstract][Full Text] [Related]
40. On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.
Greil R; Egle A; Villunger A
Leuk Lymphoma; 1998 Nov; 31(5-6):477-90. PubMed ID: 9922038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
